Discovery and evaluation of new compounds targeting ribosomal protein S1 in antibiotic-resistant Mycobacterium Tuberculosis
- 1 June 2020
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 196, 112317
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 29 references indexed in Scilit:
- Multiple activities of RNA-binding proteins S1 and HfqBiochimie, 2012
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosisScience, 2011
- Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein BindingJournal of Chemical Education, 2011
- Current development and future prospects in chemotherapy of tuberculosisRespirology, 2010
- Probing the relationship between Gram-negative and Gram-positive S1 proteins by sequence analysisNucleic Acids Research, 2009
- Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of TuberculosisAntimicrobial Agents and Chemotherapy, 2008
- S1 Ribosomal Protein Functions in Translation Initiation and Ribonuclease RegB Activation Are Mediated by Similar RNA-Protein InteractionsJournal of Biological Chemistry, 2008
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of TuberculosisAntimicrobial Agents and Chemotherapy, 2008
- Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine ModelPLOS Medicine, 2007
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995